MedPath

A multicenter, prospective observational study for severe sepsis induced by Streptococcus pneumoniae, beta-hemolytic streptococci, and Staphylococcus aureus

Not Applicable
Conditions
S. pneumonia, beta-hemolytic streptococci, and S. aureus-induced severe sepsis
Registration Number
JPRN-UMIN000019702
Lead Sponsor
Japanese Association for Acute Medicine
Brief Summary

62 were included in the current study (29 cases with S. pneumoniae sepsis and 33 with BHS). The CCI and completion of a 3-h bundle did not differ between normal and high virulence groups. Risk of 28-day mortality was significantly higher for high-virulence compared to normal-virulence when adjusted for CCI and completion of a 3-h bundle (Cox proportional hazards regression analysis, hazard ratio 3.848; 95% confidence interval, 1.108-13.370; P = 0.034).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
62
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath